Microcalorimetric method to assess phagocytosis: Macrophage-nanoparticle interactions

AAPS Journal

Volumn 13, Issue 1, 2011, Pages 20-29

  Al Hallak, M H D Kamal ^a,b   Sarfraz, Muhammad Khan ^a,c   Azarmi, Shirzad ^a,d   Kohan, M H Gilzad ^a   Roa, Wilson H ^a   Löbenberg, Raimar ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

^c THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Flow cytometry; Isothermal microcalorimetry; Macrophages; Nanoparticles; Phagocytosis

Indexed keywords

CYTOCHALASIN B; GELATIN; MANNOSYLATED GELATIN; NANOPARTICLE; POLY(ISOBUTYL 2 CYANOACRYLATE); POLYSORBATE 80; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; DRUG DOSAGE FORM; FLOW CYTOMETRY; HEAT EXCHANGE; LUNG ALVEOLUS MACROPHAGE; MICROCALORIMETRY; NONHUMAN; PHAGOCYTOSIS;

ALGORITHMS; ANIMALS; CALORIMETRY; CELL LINE; CHEMISTRY, PHARMACEUTICAL; COLLOIDS; CYANOACRYLATES; CYTOCHALASIN B; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GELATIN; MACROPHAGES; MACROPHAGES, ALVEOLAR; MICE; NANOPARTICLES; PHAGOCYTOSIS; POLYSORBATES; THERMODYNAMICS;

EID: 79951998554     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-010-9240-y     Document Type: Article

References (39)

1. Oh Y-K, Swanson JA. Different fates of phagocytosed particles after delivery into macrophage lysosomes. J Cell Biol. 1996;132 (4):585-93. (Pubitemid 26069240)
2. Schafer V, von Briesen H, Rubsamen-Waigmann H, Steffan AM, Royer C, Kreuter J. Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages. J Microencapsul. 1994;11(3):261-9. (Pubitemid 24148435)
3. Roser M, Fischer D, Kissel T. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm. 1998;46(3):255-63. (Pubitemid 29057671)
4. Al-Hallak KM, Azarmi S, Anwar-Mohamed A, Roa WH, Lobenberg R. Secondary cytotoxicity mediated by alveolar macrophages: a contribution to the total efficacy of nanoparticles in lung cancer therapy? Eur J Pharm Biopharm. 2010;76(1):112-9.
5. Soma CE, Dubernet C, Barratt G, Benita S, Couvreur P. Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro. J Control Release. 2000;68(2):283-9. (Pubitemid 30488905)
6. Chiannilkulchai N, Ammoury N, Caillou B, Devissaguet JP, Couvreur P. Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. Cancer Chemother Pharmacol. 1990;26(2):122-6. (Pubitemid 20153803)
7. Azarmi S, Roa WH, Lobenberg R. Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev. 2008;60(8):863-75.
8. Lobenberg R, Kreuter J. Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy. AIDS Res. 1996;12(18):1709-15. (Pubitemid 26424050)
9. Bender A, Schfer V, Steffan AM, Royer C, Kreuter J, Rubsamen-Waigmann H, et al. Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles. Res Virol. 1994;145(3-4):215-20. (Pubitemid 24244521)
10. Gaspar R, Preat V, Opperdoes FR, Roland M. Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production. Pharm Res. 1992;9(6):782-7.
11. Bazile D, Prud'homme C, Bassoullet MT, Marlard M, Spenlehauer G, Veillard M. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci. 1995;84(4):493-8.
12. Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res. 2003;42(6):463-78. (Pubitemid 37237636)
13. Jain SK, Gupta Y, Jain A, Saxena AR, Khare P, Jain A. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery. Nanomedicine. 2008;4(1):41-8. (Pubitemid 351324205)
14. Peracchia MT, Fattal E, Desmaele D, Besnard M, Noel JP, Gomis JM, et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Control Release. 1999;60(1):121-8. (Pubitemid 29255834)
15. Gulyaev AE, Gelperina SE, Skidan IN, Antropov AS, Kivman GY, Kreuter J. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res. 1999;16 (10):1564-9. (Pubitemid 29510553)
16. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2):283-318. (Pubitemid 32476118)
17. Alyautdin RN, Petrov VE, Langer K, Berthold A, Kharkevich DA, Kreuter J. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm Res. 1997;14(3):325-8. (Pubitemid 27160944)
18. Al-Hallak MH, Azarmi S, Sun C, Lai P, Prenner EJ, Roa WH, et al. Pulmonary toxicity of polysorbate-80-coated inhalable nanoparticles; in vitro and in vivo evaluation. AAPS J. 2010;12(3):294-9.
19. Irache JM, Salman HH, Gamazo C, Espuelas S. Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv. 2008;5(6):703-24. (Pubitemid 351998259)
20. Cui Z, Hsu CH, Mumper RJ. Physical characterization and macrophage cell uptake of mannan-coated nanoparticles. Drug Dev Ind Pharm. 2003;29(6):689-700. (Pubitemid 36835162)
21. Dutta T, Agashe HB, Garg M, Balakrishnan P, Kabra M, Jain NK. Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro. J Drug Target. 2007;15(1):89-98. (Pubitemid 47161336)
22. Rolland A, Merdrignac G, Gouranton J, Bourel D, Le Verge R, Genetet B. Flow cytometric quantitative evaluation of phagocytosis by human mononuclear and polymorphonuclear cells using fluorescent nanoparticles. J Immunol Methods. 1987;96(2):185-93. (Pubitemid 17022650)
23. Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D, L-lactide-co-glycolide) nanoparticles. Int J Pharm. 2003;262(1-2):1-11. (Pubitemid 36966688)
24. Cunningham RE. Overview of flow cytometry and fluorescent probes for cytometry. Methods Mol Biol. 1994;34:219-24.
25. Gasco MR, Bocca C, Caputo O, Cavalli R, Gabriel L, Miglietta A. Fluorescent non-stealth and stealth solid lipid nanoparticles as markers of phagocytosis by macrophages. In: Proceedings of the Controlled Release Society. 1997; p. 26.
26. Chiellini F, Dinucci D, Bartoli C, Piras AM, Chiellini E. Intracellular fate investigation of bio-eliminable polymeric nanoparticles by confocal laser scanning microscopy. J Bioact Compat Polym. 2007;22(6):667-85. (Pubitemid 350145481)
27. Al-Hallak MHDK, Xu Z, Ghaffari F, Löbenberg R. The effect of compression forces on the stability of dibasic calcium phosphate dihydrate tablets in the presence of glutamic acid hydrochloride monitored by isothermal calorimetry. Thermochim Acta. 2007;467(1-2):86-90.
28. Velazquez-Campoy A, Ohtaka H, Nezami A, Muzammil S, Freire E. Isothermal titration calorimetry. Curr Protoc Cell Biol. 2004; Chapter 17, Unit 17: 8.
29. Wasdo I. Isothermal microcalorimetry in applied biology. Thermochim Acta. 2002;394:305-11.
30. Backman P. Effects of experimental factors on the metabolic rate of T-lymphoma cells as measured by microcalorimetry. Thermochim Acta. 1990;172:123-30.
31. Sbarra AJ, Karnovsky ML. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem. 1959;234(6):1355-62.
32. Gebreselassie D, Kasravi B, Bäckman P, Jeppson B. A microcalorimetric method to study the activation of murine peritoneal macrophages. Thermochim Acta. 1996;275(1):109-15. (Pubitemid 126316154)
33. Azarmi S, Tao X, Chen H, Wang Z, Finlay WH, Lobenberg R, et al. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int J Pharm. 2006;319(1-2):155-61. (Pubitemid 44051806)
34. Alyautdin R, Gothier D, Petrov V, Kharkevich D, Kreuter J. Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles. Eur J Pharm Biopharm. 1995;41(1):44-8.
35. Azarmi S, Huang Y, Chen H, McQuarrie S, Abrams D, Roa W, et al. Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells. J Pharm Pharm Sci. 2006;9(1):124-32.
36. Axline SG, Reaven EP. Inhibition of phagocytosis and plasma membrane mobility of the cultivated macrophage by cytochalasin B. Role of subplasmalemmal microfilaments. J Cell Biol. 1974;62(3):647-59.
37. Cifarelli A, Pepe G, Paradisi F, Piccolo D. The influence of some metabolic inhibitors on phagocytic activity of mouse macrophages in vitro. Res Exp Med. 1979;174(2):197-204. (Pubitemid 9212337)
38. Zigmond SH, Hirsch JG. Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis. Exp Cell Res. 1972;73(2):383-93.
39. Malawista SE, Gee JB, Bensch KG. Cytochalasin B reversibly inhibits phagocytosis: functional, metabolic, and ultrastructural effects in human blood leukocytes and rabbit alveolar macrophages. Yale J Biol Med. 1971;44(3):286-300.